BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29967316)

  • 1. Programmed Death Receptor 1 (PD1) Knockout and Human Telomerase Reverse Transcriptase (hTERT) Transduction Can Enhance Persistence and Antitumor Efficacy of Cytokine-Induced Killer Cells Against Hepatocellular Carcinoma.
    Huang K; Sun B; Luo N; Guo H; Hu J; Peng J
    Med Sci Monit; 2018 Jul; 24():4573-4582. PubMed ID: 29967316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice.
    Jung NC; Lee JH; Choi HJ; Hwang SU; Song JY; Seo HG; Choi J; Jung SY; Han SG; Lim DS
    Immunol Invest; 2016 Aug; 45(6):553-65. PubMed ID: 27410037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma.
    Mizukoshi E; Nakamoto Y; Marukawa Y; Arai K; Yamashita T; Tsuji H; Kuzushima K; Takiguchi M; Kaneko S
    Hepatology; 2006 Jun; 43(6):1284-94. PubMed ID: 16729333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-culture of dendritic cells and cytokine-induced killer cells effectively suppresses liver cancer stem cell growth by inhibiting pathways in the immune system.
    Yang T; Zhang W; Wang L; Xiao C; Wang L; Gong Y; Huang D; Guo B; Li Q; Xiang Y; Nan Y
    BMC Cancer; 2018 Oct; 18(1):984. PubMed ID: 30326865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo.
    Wang FS; Liu MX; Zhang B; Shi M; Lei ZY; Sun WB; Du QY; Chen JM
    World J Gastroenterol; 2002 Jun; 8(3):464-8. PubMed ID: 12046071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
    González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH
    Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High number of PD-1 positive intratumoural lymphocytes predicts survival benefit of cytokine-induced killer cells for hepatocellular carcinoma patients.
    Chang B; Shen L; Wang K; Jin J; Huang T; Chen Q; Li W; Wu P
    Liver Int; 2018 Aug; 38(8):1449-1458. PubMed ID: 29356308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of cytokine-induced killer cell with valproate inhibits growth of hepatocellular carcinoma cell in a mouse model.
    Lee DH; Nam JY; Chang Y; Cho H; Kang SH; Cho YY; Cho E; Lee JH; Yu SJ; Kim YJ; Yoon JH
    Cancer Biol Ther; 2017 Jan; 18(1):67-75. PubMed ID: 28055304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro cytotox icity effects of cocultured DC-C IK cells combined with sorafenib against hepa to cellular carcinoma].
    Zhang D; He JT
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):664-7. PubMed ID: 21651871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis.
    Yu R; Yang B; Chi X; Cai L; Liu C; Yang L; Wang X; He P; Lu X
    Drug Des Devel Ther; 2017; 11():851-864. PubMed ID: 28360510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma.
    Hui D; Qiang L; Jian W; Ti Z; Da-Lu K
    Dig Liver Dis; 2009 Jan; 41(1):36-41. PubMed ID: 18818130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of different procedures for the separation of peripheral blood mononuclear cells in cytokine-induced killer cell immunotherapy for hepatocarcinoma.
    Liu H; Li J; Wang F; Gao Y; Luo Y; Wang P; Li C; Zhu Z
    Tumour Biol; 2015 Apr; 36(4):2299-307. PubMed ID: 25417201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
    Pan K; Li YQ; Wang W; Xu L; Zhang YJ; Zheng HX; Zhao JJ; Qiu HJ; Weng DS; Li JJ; Wang QJ; Huang LX; He J; Chen SP; Ke ML; Wu PH; Chen MS; Li SP; Xia JC; Zeng YX
    Ann Surg Oncol; 2013 Dec; 20(13):4305-11. PubMed ID: 23892527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Combined Antitumor Effects of
    Zhang J; Wu N; Lian Z; Feng H; Jiang Q; Chen X; Gong J; Qiao Z
    Technol Cancer Res Treat; 2017 Dec; 16(6):1083-1091. PubMed ID: 29332456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma.
    Pan QZ; Liu Q; Zhou YQ; Zhao JJ; Wang QJ; Li YQ; Tang Y; Gu JM; He J; Chen SP; Weng DS; Xia JC
    Cancer Immunol Immunother; 2020 May; 69(5):825-834. PubMed ID: 32060687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suicide gene-modified killer cells as an allogeneic alternative to autologous cytokine-induced killer cell immunotherapy of hepatocellular carcinoma.
    Wu T; Leboeuf C; Durand S; Su B; Deschamps M; Zhang X; Ferrand C; Pessaux P; Robinet E
    Mol Med Rep; 2016 Mar; 13(3):2645-54. PubMed ID: 26820174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer.
    Dai C; Lin F; Geng R; Ge X; Tang W; Chang J; Wu Z; Liu X; Lin Y; Zhang Z; Li J
    Oncotarget; 2016 Mar; 7(9):10332-44. PubMed ID: 26871284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killing efficiency affected by mutually modulated PD-1 and PD-L1 expression via NKT-hepatoma cell interactions.
    Liu L; Yang M; Xu Q; Zhou M; Cheng Y; Xu H; Qin Y; Liu B
    Immunotherapy; 2021 Feb; 13(2):113-123. PubMed ID: 33076728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.